Literature DB >> 20080098

History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Stuart Jon Spechler1, Rebecca C Fitzgerald, Ganapathy A Prasad, Kenneth K Wang.   

Abstract

This report is an adjunct to the American Gastroenterological Association Institute's medical position statement and technical review on the management of Barrett's esophagus, which will be published in the near future. Those documents will consider a number of broad questions on the diagnosis, clinical features, and management of patients with Barrett's esophagus, and the reader is referred to the technical review for an in-depth discussion of those topics. In this report, we review historical, molecular, and endoscopic therapeutic aspects of Barrett's esophagus that are of interest to clinicians and researchers. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20080098      PMCID: PMC2853870          DOI: 10.1053/j.gastro.2010.01.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  162 in total

1.  Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.

Authors:  Krish Ragunath; Neville Krasner; V Sankara Raman; Mustafa T Haqqani; Ceri J Phillips; Ivy Cheung
Journal:  Scand J Gastroenterol       Date:  2005-07       Impact factor: 2.423

2.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.

Authors:  R E Sampliner; D Faigel; M B Fennerty; D Lieberman; A Ippoliti; K Lewin; W M Weinstein
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

3.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.

Authors:  M K Hong; W B Laskin; B E Herman; M H Johnston; J J Vargo; S M Steinberg; C J Allegra; P G Johnston
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

5.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

6.  Endoscopic Mucosal Resection: Esophageal Applications.

Authors:  Granapathy Prasad; Kenneth K Wang
Journal:  Curr Treat Options Gastroenterol       Date:  2005-02

7.  Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway.

Authors:  Kathy Hormi-Carver; Xi Zhang; Hui Ying Zhang; Robert H Whitehead; Lance S Terada; Stuart J Spechler; Rhonda F Souza
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

8.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

Review 9.  Total endoscopic resection of Barrett esophagus.

Authors:  S Seewald; T L Ang; T Gotoda; N Soehendra
Journal:  Endoscopy       Date:  2008-12-08       Impact factor: 10.093

Review 10.  Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.

Authors:  Christopher P Wild; Laura J Hardie
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

View more
  67 in total

1.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

2.  Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation.

Authors:  Mariana Milashka; Annabelle Calomme; Jean Luc Van Laethem; Daniel Blero; Pierre Eisendrath; Olivier Le Moine; Jacques Devière
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

3.  Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.

Authors:  Daniel Castillo; Sonia Puig; Mar Iglesias; Agustín Seoane; Carme de Bolós; Vicente Munitiz; Pascual Parrilla; Laura Comerma; Richard Poulsom; Kausilia K Krishnadath; Luís Grande; Manuel Pera
Journal:  J Gastrointest Surg       Date:  2011-11-11       Impact factor: 3.452

4.  Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus.

Authors:  Elizabeth L Bird-Lieberman; André A Neves; Pierre Lao-Sirieix; Maria O'Donovan; Marco Novelli; Laurence B Lovat; William S Eng; Lara K Mahal; Kevin M Brindle; Rebecca C Fitzgerald
Journal:  Nat Med       Date:  2012-01-15       Impact factor: 53.440

5.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

Review 6.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 7.  Barrett's esophagus: Clinical issues.

Authors:  Stuart Jon Spechler
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-01

8.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

Review 9.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 10.  Quality improvement in gastroenterology clinical practice.

Authors:  Rakhi Kheraj; Sumeet K Tewani; Gyanprakash Ketwaroo; Daniel A Leffler
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.